Cardiol Therapeutics Completes US$11.4 Million Financing and Extends Cash Runway into Q3 2027
MAVERIC Phase III pivotal trial of orphan drug candidate CardiolRx in recurrent pericarditis is fully funded through to a planned New Drug
MAVERIC Phase III pivotal trial of orphan drug candidate CardiolRx in recurrent pericarditis is fully funded through to a planned New Drug
United States Antimony (NYSE:UAMY) said on Sunday (October 19) that it is proposing to acquire Australian company Larvotto Resources (ASX:LRV). In a takeover
China has accused the US of “seriously distorting and exaggerating” Beijing’s newly expanded rare earths export controls, but signaled a willingness to
Gold Fields (NYSE:GFI) has completed its AU$3.7 billion purchase of Gold Road Resources. Gold Road rejected Gold Fields’ first acquisition proposal in March,
Jindalee Lithium (JLL:AU) has announced Proposed issue of securities – JLL Download the PDF here. This post appeared first on investingnews.com
Here’s a quick recap of the crypto landscape for Friday (October 17) as of 9:00 p.m. UTC. Get the latest insights on
Atlantic Lithium (A11:AU) has announced Pronounced Lithium-in-soil Anomalies Download the PDF here. This post appeared first on investingnews.com
Trading resumes in: Company: Cardiol Therapeutics Inc. TSX Symbol: CRDL All Issues: Yes Resumption (ET): 8:00 AM CIRO can make a decision to impose a temporary suspension
(TheNewswire)
Manhattan Showing with assay results returning uranium grades ranging from 0.72% to 8.10% U3O8 in outcrop grab samples. Standard Uranium Ltd. (TSXV: STND,OTC:STTDF) (OTCQB: